Cell cycle regulation of the endogenous wild type Bloom's syndrome DNA helicase

被引:102
作者
Dutertre, S
Ababou, M
Onclercq, R
Delic, J
Chatton, B
Jaulin, C
Amor-Guéret, M
机构
[1] Inst Gustave Roussy, CNRS, UMR 1598, F-94805 Villejuif, France
[2] Inst Curie, Lab Radiopathol, CEA, Lab Rech Correspondant,DSV,DRR, F-75005 Paris, France
[3] ULP, CNRS, INSERM, Inst Genet & Biol Mol & Cellulaire, F-67404 Illkirch, CU De Strasbour, France
关键词
Bloom's syndrome; RecQ 3 '-5 ' DNA helicase; cell cycle; post-translational modifications; cancer predisposition;
D O I
10.1038/sj.onc.1203595
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Bloom's syndrome (BS) is a rare human autosomal recessive disorder characterized by an increased risk to develop cancer of all types, BS cells are characterized by a generalized genetic instability including a high level of sister chromatid exchanges, BS arises through mutations in both alleles of the BLM gene which encodes a 3'-5' DNA helicase identified as a member of the RecQ family. We developed polyclonal antibodies specific for the NH2- and COOH-terminal region of BLM, Using these antibodies, we analysed BLM expression during the cell cycle and showed that the BLM protein accumulates to high levels in S phase, persists in G2/M and sharply declines in G1, strongly suggestive of degradation during mitosis, The BLM protein is subject to post-translational modifications in mitosis, as revealed by slow migrating forms of BLM found in both demecolcine-treated cells and in mitotic cells isolated from non-treated asynchronous populations. Phosphatase treatment indicated that phosphorylation events were solely responsible for the appearance of the retarded moieties, a possible signal for subsequent degradation. Together, these results are consistent with a role of BLM in a replicative (S phase) and/or post-replicative (G2 phase) process.
引用
收藏
页码:2731 / 2738
页数:8
相关论文
共 42 条
  • [1] beta-catenin is a target for the ubiquitin-proteasome pathway
    Aberle, H
    Bauer, A
    Stappert, J
    Kispert, A
    Kemler, R
    [J]. EMBO JOURNAL, 1997, 16 (13) : 3797 - 3804
  • [2] Point mutations causing Bloom's syndrome abolish ATPase and DNA helicase activities of the BLM protein
    Bahr, A
    De Graeve, F
    Kedinger, C
    Chatton, B
    [J]. ONCOGENE, 1998, 17 (20) : 2565 - 2571
  • [3] Chakraverty RK, 1999, BIOESSAYS, V21, P286
  • [4] Stage-specific apoptosis, developmental delay, and embryonic lethality in mice homozygous for a targeted disruption in the murine Bloom's syndrome gene
    Chester, N
    Kuo, F
    Kozak, C
    O'Hara, CD
    Leder, P
    [J]. GENES & DEVELOPMENT, 1998, 12 (21) : 3382 - 3393
  • [5] Turnover of cyclin E by the ubiquitin-proteasome pathway is regulated by cdk2 binding and cyclin phosphorylation
    Clurman, BE
    Sheaff, RJ
    Thress, K
    Groudine, M
    Roberts, JM
    [J]. GENES & DEVELOPMENT, 1996, 10 (16) : 1979 - 1990
  • [6] COUX O, 1996, ANNU REV BIOCHEM, V65, P80
  • [7] THE BLOOMS-SYNDROME GENE-PRODUCT IS HOMOLOGOUS TO RECQ HELICASES
    ELLIS, NA
    GRODEN, J
    YE, TZ
    STRAUGHEN, J
    LENNON, DJ
    CIOCCI, S
    PROYTCHEVA, M
    GERMAN, J
    [J]. CELL, 1995, 83 (04) : 655 - 666
  • [8] INHIBITION OF PROTEASOME ACTIVITIES AND SUBUNIT-SPECIFIC AMINO-TERMINAL THREONINE MODIFICATION BY LACTACYSTIN
    FENTEANY, G
    STANDAERT, RF
    LANE, WS
    CHOI, S
    COREY, EJ
    SCHREIBER, SL
    [J]. SCIENCE, 1995, 268 (5211) : 726 - 731
  • [9] Frei C, 2000, GENE DEV, V14, P81
  • [10] THE YEAST TYPE-I TOPOISOMERASE TOP3 INTERACTS WITH SGS1, A DNA HELICASE HOMOLOG - A POTENTIAL EUKARYOTIC REVERSE GYRASE
    GANGLOFF, S
    MCDONALD, JP
    BENDIXEN, C
    ARTHUR, L
    ROTHSTEIN, R
    [J]. MOLECULAR AND CELLULAR BIOLOGY, 1994, 14 (12) : 8391 - 8398